- £81.91bn
- £95.80bn
- £32.67bn
REG - GSK PLC - GSK completes acquisition of BELLUS Health
AnnouncementREG - GSK PLC - FDA Fast Track for Gonorrhoea Vaccine Candidate
AnnouncementREG - GSK PLC - Shingrix approved in Japan for adults 18 and over
AnnouncementREG - GSK PLC - GSK daprodustat gains positive EMA CHMP opinion
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Statement: Zantac (ranitidine) litigation
AnnouncementREG - GSK PLC - GSK’s Arexvy recommended by ACIP
AnnouncementREG - GSK PLC - Season two data for GSK Arexvy RSV OA vaccine
AnnouncementREG - GSK PLC - Extension of FDA review period for momelotinib
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - EU authorisation of GSK’s RSV vaccine Arexvy
AnnouncementREG - GSK PLC - GSK receives US FDA file acceptance for Jemperli
AnnouncementREG - Allianz Glbl Inv - Top 10 Holdings
AnnouncementREG - GSK PLC - Total Voting Rights
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - Haleon PLC GSK PLC - Holding(s) in Company
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
Announcement